

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transmembrane transport (GO:0006855) | 6.74383272 |
| 2 | urate metabolic process (GO:0046415) | 6.68604328 |
| 3 | angiotensin maturation (GO:0002003) | 6.36023393 |
| 4 | lysine metabolic process (GO:0006553) | 6.18748119 |
| 5 | lysine catabolic process (GO:0006554) | 6.18748119 |
| 6 | glycosphingolipid catabolic process (GO:0046479) | 6.16713941 |
| 7 | drug transport (GO:0015893) | 5.81724818 |
| 8 | glycolipid catabolic process (GO:0019377) | 5.73966525 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.73620302 |
| 10 | cysteine metabolic process (GO:0006534) | 5.45714031 |
| 11 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.41584845 |
| 12 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.40421274 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.25684265 |
| 14 | L-phenylalanine catabolic process (GO:0006559) | 5.25684265 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.21169018 |
| 16 | L-phenylalanine metabolic process (GO:0006558) | 5.21169018 |
| 17 | oligosaccharide catabolic process (GO:0009313) | 5.11487469 |
| 18 | drug catabolic process (GO:0042737) | 5.01310974 |
| 19 | organic cation transport (GO:0015695) | 4.99570802 |
| 20 | ceramide catabolic process (GO:0046514) | 4.91617550 |
| 21 | aromatic amino acid family catabolic process (GO:0009074) | 4.90672044 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.83578516 |
| 23 | adhesion of symbiont to host cell (GO:0044650) | 4.80930523 |
| 24 | virion attachment to host cell (GO:0019062) | 4.80930523 |
| 25 | exogenous drug catabolic process (GO:0042738) | 4.66892235 |
| 26 | phosphate ion transport (GO:0006817) | 4.62365358 |
| 27 | response to mercury ion (GO:0046689) | 4.61591293 |
| 28 | indole-containing compound catabolic process (GO:0042436) | 4.56363485 |
| 29 | indolalkylamine catabolic process (GO:0046218) | 4.56363485 |
| 30 | tryptophan catabolic process (GO:0006569) | 4.56363485 |
| 31 | homocysteine metabolic process (GO:0050667) | 4.49125057 |
| 32 | short-chain fatty acid metabolic process (GO:0046459) | 4.47021619 |
| 33 | tricarboxylic acid metabolic process (GO:0072350) | 4.39659935 |
| 34 | sphingolipid catabolic process (GO:0030149) | 4.38720528 |
| 35 | tryptophan metabolic process (GO:0006568) | 4.36692752 |
| 36 | quaternary ammonium group transport (GO:0015697) | 4.36288464 |
| 37 | regulation of mononuclear cell migration (GO:0071675) | 4.35821327 |
| 38 | valine metabolic process (GO:0006573) | 4.34011106 |
| 39 | membrane lipid catabolic process (GO:0046466) | 4.29834813 |
| 40 | sulfur amino acid catabolic process (GO:0000098) | 4.26566867 |
| 41 | amino-acid betaine metabolic process (GO:0006577) | 4.20672141 |
| 42 | cellular modified amino acid catabolic process (GO:0042219) | 4.18482852 |
| 43 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.16386747 |
| 44 | aspartate family amino acid catabolic process (GO:0009068) | 4.12628604 |
| 45 | adhesion of symbiont to host (GO:0044406) | 4.11957067 |
| 46 | serine family amino acid catabolic process (GO:0009071) | 4.10733535 |
| 47 | branched-chain amino acid metabolic process (GO:0009081) | 4.02265917 |
| 48 | phosphate ion transmembrane transport (GO:0035435) | 4.02264342 |
| 49 | fatty acid beta-oxidation (GO:0006635) | 3.96828289 |
| 50 | kynurenine metabolic process (GO:0070189) | 3.95098594 |
| 51 | vitamin D metabolic process (GO:0042359) | 3.94960842 |
| 52 | 2-oxoglutarate metabolic process (GO:0006103) | 3.93431220 |
| 53 | amino sugar catabolic process (GO:0046348) | 3.83179515 |
| 54 | fatty acid oxidation (GO:0019395) | 3.82113217 |
| 55 | peptide catabolic process (GO:0043171) | 3.80080482 |
| 56 | lipid oxidation (GO:0034440) | 3.77106522 |
| 57 | alpha-linolenic acid metabolic process (GO:0036109) | 3.73379862 |
| 58 | regulation of vitamin metabolic process (GO:0030656) | 3.64794574 |
| 59 | serine family amino acid metabolic process (GO:0009069) | 3.63278687 |
| 60 | carnitine metabolic process (GO:0009437) | 3.61725382 |
| 61 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.59025622 |
| 62 | aromatic amino acid family metabolic process (GO:0009072) | 3.57442930 |
| 63 | renal absorption (GO:0070293) | 3.57334253 |
| 64 | immunoglobulin mediated immune response (GO:0016064) | 3.55188147 |
| 65 | branched-chain amino acid catabolic process (GO:0009083) | 3.53071103 |
| 66 | cellular ketone body metabolic process (GO:0046950) | 3.52861686 |
| 67 | alpha-amino acid catabolic process (GO:1901606) | 3.52098845 |
| 68 | cellular amino acid catabolic process (GO:0009063) | 3.52075783 |
| 69 | acetyl-CoA metabolic process (GO:0006084) | 3.50315425 |
| 70 | excretion (GO:0007588) | 3.48824286 |
| 71 | fatty acid catabolic process (GO:0009062) | 3.47914494 |
| 72 | toxin transport (GO:1901998) | 3.46245492 |
| 73 | amino-acid betaine transport (GO:0015838) | 3.46224485 |
| 74 | carnitine transport (GO:0015879) | 3.46224485 |
| 75 | bile acid biosynthetic process (GO:0006699) | 3.45192481 |
| 76 | T-helper 1 type immune response (GO:0042088) | 3.43681322 |
| 77 | flavonoid metabolic process (GO:0009812) | 3.43371736 |
| 78 | lipoprotein transport (GO:0042953) | 3.43320117 |
| 79 | NADH metabolic process (GO:0006734) | 3.41835957 |
| 80 | fructose metabolic process (GO:0006000) | 3.40959800 |
| 81 | glutamate metabolic process (GO:0006536) | 3.38340606 |
| 82 | monocarboxylic acid catabolic process (GO:0072329) | 3.33891723 |
| 83 | regulation of cellular extravasation (GO:0002691) | 3.32918569 |
| 84 | benzene-containing compound metabolic process (GO:0042537) | 3.30753643 |
| 85 | carboxylic acid catabolic process (GO:0046395) | 3.29323813 |
| 86 | organic acid catabolic process (GO:0016054) | 3.29323813 |
| 87 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.29122332 |
| 88 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.28131563 |
| 89 | barbed-end actin filament capping (GO:0051016) | 3.27881375 |
| 90 | drug metabolic process (GO:0017144) | 3.27589131 |
| 91 | proline metabolic process (GO:0006560) | 3.27217208 |
| 92 | regulation of fever generation (GO:0031620) | 3.26302687 |
| 93 | modified amino acid transport (GO:0072337) | 3.23090949 |
| 94 | eosinophil chemotaxis (GO:0048245) | 3.22178683 |
| 95 | regulation of cholesterol esterification (GO:0010872) | 3.21536132 |
| 96 | regulation of cholesterol homeostasis (GO:2000188) | 3.19974433 |
| 97 | negative regulation of interleukin-12 production (GO:0032695) | 3.19902517 |
| 98 | ethanol oxidation (GO:0006069) | 3.19439477 |
| 99 | biotin metabolic process (GO:0006768) | 3.19088890 |
| 100 | response to growth hormone (GO:0060416) | 3.17339026 |
| 101 | indolalkylamine metabolic process (GO:0006586) | 3.16941315 |
| 102 | regulation of podosome assembly (GO:0071801) | 3.16657387 |
| 103 | regulation of cholesterol storage (GO:0010885) | 3.16259569 |
| 104 | monocyte chemotaxis (GO:0002548) | 3.15884070 |
| 105 | urea cycle (GO:0000050) | 3.14875659 |
| 106 | urea metabolic process (GO:0019627) | 3.14875659 |
| 107 | cellular glucuronidation (GO:0052695) | 3.14222228 |
| 108 | regulation of guanylate cyclase activity (GO:0031282) | 3.13729033 |
| 109 | glucuronate metabolic process (GO:0019585) | 3.13653165 |
| 110 | uronic acid metabolic process (GO:0006063) | 3.13653165 |
| 111 | serine family amino acid biosynthetic process (GO:0009070) | 3.13511906 |
| 112 | phosphate ion homeostasis (GO:0055062) | 3.13141138 |
| 113 | trivalent inorganic anion homeostasis (GO:0072506) | 3.13141138 |
| 114 | glycosylceramide metabolic process (GO:0006677) | 3.11738483 |
| 115 | phospholipid efflux (GO:0033700) | 3.09662822 |
| 116 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.08654673 |
| 117 | ketone body metabolic process (GO:1902224) | 3.07568363 |
| 118 | protein carboxylation (GO:0018214) | 3.06606900 |
| 119 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.06606900 |
| 120 | response to phenylpropanoid (GO:0080184) | 3.04026903 |
| 121 | complement activation, alternative pathway (GO:0006957) | 3.03593572 |
| 122 | glutathione biosynthetic process (GO:0006750) | 3.02109376 |
| 123 | cyclooxygenase pathway (GO:0019371) | 3.01723344 |
| 124 | vitamin biosynthetic process (GO:0009110) | 3.01706243 |
| 125 | aldehyde catabolic process (GO:0046185) | 3.00969346 |
| 126 | tyrosine metabolic process (GO:0006570) | 3.00441850 |
| 127 | positive regulation of antigen processing and presentation (GO:0002579) | 2.99094010 |
| 128 | cellular biogenic amine catabolic process (GO:0042402) | 2.98488441 |
| 129 | amine catabolic process (GO:0009310) | 2.98488441 |
| 130 | nitrogen cycle metabolic process (GO:0071941) | 2.97994972 |
| 131 | positive regulation of heat generation (GO:0031652) | 2.97544039 |
| 132 | regulation of macrophage chemotaxis (GO:0010758) | 2.95467786 |
| 133 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.94677208 |
| 134 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.94329399 |
| 135 | sodium-independent organic anion transport (GO:0043252) | 2.93230471 |
| 136 | eosinophil migration (GO:0072677) | 2.93220059 |
| 137 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.92608272 |
| 138 | NADP metabolic process (GO:0006739) | 2.91467024 |
| 139 | response to peptidoglycan (GO:0032494) | 2.90661736 |
| 140 | 4-hydroxyproline metabolic process (GO:0019471) | 2.88496164 |
| 141 | L-ascorbic acid metabolic process (GO:0019852) | 2.88063671 |
| 142 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.87816906 |
| 143 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.87816906 |
| 144 | bile acid metabolic process (GO:0008206) | 2.87679940 |
| 145 | regulation of antigen processing and presentation (GO:0002577) | 2.85202707 |
| 146 | transcytosis (GO:0045056) | 2.83791230 |
| 147 | epoxygenase P450 pathway (GO:0019373) | 2.83005050 |
| 148 | small molecule catabolic process (GO:0044282) | 2.82651264 |
| 149 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.82259989 |
| 150 | myeloid dendritic cell differentiation (GO:0043011) | 2.82119539 |
| 151 | glycoside metabolic process (GO:0016137) | 2.79949469 |
| 152 | neutrophil activation involved in immune response (GO:0002283) | 2.77041112 |
| 153 | NIK/NF-kappaB signaling (GO:0038061) | 2.75114191 |
| 154 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.74017708 |
| 155 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.73050978 |
| 156 | keratan sulfate catabolic process (GO:0042340) | 2.70816142 |
| 157 | fat-soluble vitamin metabolic process (GO:0006775) | 2.70010270 |
| 158 | cellular response to type I interferon (GO:0071357) | 2.69859911 |
| 159 | type I interferon signaling pathway (GO:0060337) | 2.69859911 |
| 160 | B cell mediated immunity (GO:0019724) | 2.65613010 |
| 161 | macrophage activation involved in immune response (GO:0002281) | 2.65560304 |
| 162 | N-acetylneuraminate metabolic process (GO:0006054) | 2.64351404 |
| 163 | response to type I interferon (GO:0034340) | 2.63542518 |
| 164 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.62092181 |
| 165 | plasma lipoprotein particle assembly (GO:0034377) | 2.61035852 |
| 166 | detection of other organism (GO:0098543) | 2.57952247 |
| 167 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.57559665 |
| 168 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.56998042 |
| 169 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.56998042 |
| 170 | endocrine process (GO:0050886) | 2.56998042 |
| 171 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.54091701 |
| 172 | lipoprotein metabolic process (GO:0042157) | 2.53194009 |
| 173 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.52165393 |
| 174 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.51693055 |
| 175 | regulation of monocyte chemotaxis (GO:0090025) | 2.49791689 |
| 176 | amyloid precursor protein catabolic process (GO:0042987) | 2.49579772 |
| 177 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.48562807 |
| 178 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.47581069 |
| 179 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.46723274 |
| 180 | protein-lipid complex assembly (GO:0065005) | 2.46229618 |
| 181 | response to interferon-beta (GO:0035456) | 2.45576962 |
| 182 | apoptotic cell clearance (GO:0043277) | 2.45093531 |
| 183 | positive regulation of pseudopodium assembly (GO:0031274) | 2.44059232 |
| 184 | cellular response to interferon-gamma (GO:0071346) | 2.44035629 |
| 185 | regulation of chemokine biosynthetic process (GO:0045073) | 2.43558696 |
| 186 | diacylglycerol metabolic process (GO:0046339) | 2.43508641 |
| 187 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.43376659 |
| 188 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.43194577 |
| 189 | regulation of heat generation (GO:0031650) | 2.42782746 |
| 190 | detection of bacterium (GO:0016045) | 2.42220444 |
| 191 | intestinal absorption (GO:0050892) | 2.41436062 |
| 192 | regulation of superoxide anion generation (GO:0032928) | 2.40248526 |
| 193 | cholesterol efflux (GO:0033344) | 2.40146291 |
| 194 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.38007546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.63409320 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.77314136 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.15411251 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.08019339 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.57301750 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.35308746 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.12992934 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.66016135 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.64288844 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.59601893 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.53432591 |
| 12 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.51618238 |
| 13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.47518031 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.16936005 |
| 15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.16258042 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.16236050 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.12839953 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.12838097 |
| 19 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.09955954 |
| 20 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.08673521 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.03249780 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.98831813 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.95207363 |
| 24 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.91449527 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.76110175 |
| 26 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.73877309 |
| 27 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69697224 |
| 28 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.61487360 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.61044210 |
| 30 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.60183593 |
| 31 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.60183593 |
| 32 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.60183593 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.59124266 |
| 34 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.59065368 |
| 35 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.58158965 |
| 36 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.58121729 |
| 37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.57408876 |
| 38 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.54598115 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.50535559 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.47255465 |
| 41 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.46983780 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.46077782 |
| 43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.43597831 |
| 44 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.43454160 |
| 45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41077214 |
| 46 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.40959789 |
| 47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.39914271 |
| 48 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.39046842 |
| 49 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.37389685 |
| 50 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.36987800 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.33575680 |
| 52 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.32512223 |
| 53 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32094371 |
| 54 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.26027153 |
| 55 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.25778293 |
| 56 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.25249170 |
| 57 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25188323 |
| 58 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22969691 |
| 59 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.22692419 |
| 60 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.22098306 |
| 61 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.19874227 |
| 62 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.18350869 |
| 63 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.18260690 |
| 64 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.17918521 |
| 65 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.17630262 |
| 66 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17460793 |
| 67 | SPI1_23127762_ChIP-Seq_K562_Human | 1.16982614 |
| 68 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.16174887 |
| 69 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.16144351 |
| 70 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15646484 |
| 71 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.13647681 |
| 72 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.12888546 |
| 73 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.12430931 |
| 74 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.12283341 |
| 75 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.11310250 |
| 76 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.10812950 |
| 77 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08578835 |
| 78 | SA1_27219007_Chip-Seq_Bcells_Human | 1.07781468 |
| 79 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.06746422 |
| 80 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.06746422 |
| 81 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.06617058 |
| 82 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06437893 |
| 83 | GATA1_22025678_ChIP-Seq_K562_Human | 1.06081967 |
| 84 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.05952612 |
| 85 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.05049088 |
| 86 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.03642583 |
| 87 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03361915 |
| 88 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03117822 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02507795 |
| 90 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02155374 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01863073 |
| 92 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01584281 |
| 93 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00639546 |
| 94 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00341917 |
| 95 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00098346 |
| 96 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.99673896 |
| 97 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.98515897 |
| 98 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98364563 |
| 99 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98325412 |
| 100 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97893554 |
| 101 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.97887272 |
| 102 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97486810 |
| 103 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96750776 |
| 104 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95813737 |
| 105 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95585477 |
| 106 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95178205 |
| 107 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94185402 |
| 108 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.94050324 |
| 109 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93636178 |
| 110 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91409364 |
| 111 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91170916 |
| 112 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.90447624 |
| 113 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90196608 |
| 114 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.88769298 |
| 115 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85659803 |
| 116 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.84258537 |
| 117 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.83694926 |
| 118 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83578047 |
| 119 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.83377228 |
| 120 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82751500 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.80722974 |
| 122 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80267631 |
| 123 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79666529 |
| 124 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.79366605 |
| 125 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78440060 |
| 126 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76000496 |
| 127 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76000496 |
| 128 | CJUN_26792858_Chip-Seq_BT549_Human | 0.74184214 |
| 129 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.73193732 |
| 130 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.72961890 |
| 131 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.72649953 |
| 132 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.72216822 |
| 133 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71602571 |
| 134 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.71328168 |
| 135 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71111054 |
| 136 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.70769906 |
| 137 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.70222403 |
| 138 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.69613572 |
| 139 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.69222498 |
| 140 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.68752401 |
| 141 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.67578329 |
| 142 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.66967048 |
| 143 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65401641 |
| 144 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64933373 |
| 145 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.64692073 |
| 146 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.64331592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.98934487 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.42562317 |
| 3 | MP0003303_peritoneal_inflammation | 4.10486205 |
| 4 | MP0005332_abnormal_amino_acid | 3.61463851 |
| 5 | MP0004019_abnormal_vitamin_homeostasis | 3.56193072 |
| 6 | MP0005365_abnormal_bile_salt | 3.48850313 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.42226162 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.36430794 |
| 9 | MP0004043_abnormal_pH_regulation | 3.19841626 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 3.16616879 |
| 11 | MP0003195_calcinosis | 2.93918084 |
| 12 | MP0009643_abnormal_urine_homeostasis | 2.89544370 |
| 13 | MP0003252_abnormal_bile_duct | 2.84244491 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.81094164 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.52702316 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.42028748 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 2.34727316 |
| 18 | MP0009840_abnormal_foam_cell | 2.20603478 |
| 19 | MP0009785_altered_susceptibility_to | 2.19483790 |
| 20 | MP0001756_abnormal_urination | 2.12637642 |
| 21 | MP0001765_abnormal_ion_homeostasis | 2.11848029 |
| 22 | MP0010155_abnormal_intestine_physiology | 2.03186904 |
| 23 | MP0010329_abnormal_lipoprotein_level | 2.03156366 |
| 24 | MP0005636_abnormal_mineral_homeostasis | 2.01677761 |
| 25 | MP0002136_abnormal_kidney_physiology | 1.98807530 |
| 26 | MP0004510_myositis | 1.96130566 |
| 27 | MP0001666_abnormal_nutrient_absorption | 1.86719191 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.83788749 |
| 29 | MP0001835_abnormal_antigen_presentation | 1.83654951 |
| 30 | MP0005025_abnormal_response_to | 1.80158958 |
| 31 | MP0003724_increased_susceptibility_to | 1.78555032 |
| 32 | MP0001958_emphysema | 1.78118337 |
| 33 | MP0001790_abnormal_immune_system | 1.74518178 |
| 34 | MP0005387_immune_system_phenotype | 1.74518178 |
| 35 | MP0003186_abnormal_redox_activity | 1.65359436 |
| 36 | MP0005319_abnormal_enzyme/_coenzyme | 1.63985581 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56372090 |
| 38 | MP0005671_abnormal_response_to | 1.51673610 |
| 39 | MP0010368_abnormal_lymphatic_system | 1.51607537 |
| 40 | MP0003329_amyloid_beta_deposits | 1.50993813 |
| 41 | MP0001853_heart_inflammation | 1.50836661 |
| 42 | MP0002118_abnormal_lipid_homeostasis | 1.48213500 |
| 43 | MP0005000_abnormal_immune_tolerance | 1.42951265 |
| 44 | MP0005670_abnormal_white_adipose | 1.42767881 |
| 45 | MP0000609_abnormal_liver_physiology | 1.41841768 |
| 46 | MP0003878_abnormal_ear_physiology | 1.40256969 |
| 47 | MP0005377_hearing/vestibular/ear_phenot | 1.40256969 |
| 48 | MP0005257_abnormal_intraocular_pressure | 1.39132956 |
| 49 | MP0005083_abnormal_biliary_tract | 1.37372472 |
| 50 | MP0002452_abnormal_antigen_presenting | 1.36632839 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 1.35704094 |
| 52 | MP0003448_altered_tumor_morphology | 1.31070686 |
| 53 | MP0008260_abnormal_autophagy | 1.23554229 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.18697094 |
| 55 | MP0002723_abnormal_immune_serum | 1.18617577 |
| 56 | MP0001764_abnormal_homeostasis | 1.18008292 |
| 57 | MP0006054_spinal_hemorrhage | 1.14914790 |
| 58 | MP0000490_abnormal_crypts_of | 1.13494663 |
| 59 | MP0009764_decreased_sensitivity_to | 1.12463178 |
| 60 | MP0005084_abnormal_gallbladder_morpholo | 1.11626448 |
| 61 | MP0001849_ear_inflammation | 1.09275150 |
| 62 | MP0000685_abnormal_immune_system | 1.09040561 |
| 63 | MP0005451_abnormal_body_composition | 1.08746167 |
| 64 | MP0003453_abnormal_keratinocyte_physiol | 1.08192639 |
| 65 | MP0005310_abnormal_salivary_gland | 1.07861108 |
| 66 | MP0005167_abnormal_blood-brain_barrier | 1.07076524 |
| 67 | MP0008469_abnormal_protein_level | 1.04585742 |
| 68 | MP0000538_abnormal_urinary_bladder | 1.02561564 |
| 69 | MP0000858_altered_metastatic_potential | 1.01768381 |
| 70 | MP0003879_abnormal_hair_cell | 1.00539595 |
| 71 | MP0004947_skin_inflammation | 0.99146141 |
| 72 | MP0002928_abnormal_bile_duct | 0.98574172 |
| 73 | MP0001800_abnormal_humoral_immune | 0.98533784 |
| 74 | MP0004272_abnormal_basement_membrane | 0.98427968 |
| 75 | MP0002168_other_aberrant_phenotype | 0.97538606 |
| 76 | MP0001879_abnormal_lymphatic_vessel | 0.97526617 |
| 77 | MP0004264_abnormal_extraembryonic_tissu | 0.95531134 |
| 78 | MP0003436_decreased_susceptibility_to | 0.95372955 |
| 79 | MP0005666_abnormal_adipose_tissue | 0.95340277 |
| 80 | MP0001819_abnormal_immune_cell | 0.95037955 |
| 81 | MP0000230_abnormal_systemic_arterial | 0.94859514 |
| 82 | MP0008438_abnormal_cutaneous_collagen | 0.94817289 |
| 83 | MP0000598_abnormal_liver_morphology | 0.93738966 |
| 84 | MP0003075_altered_response_to | 0.93524523 |
| 85 | MP0002135_abnormal_kidney_morphology | 0.93152306 |
| 86 | MP0002420_abnormal_adaptive_immunity | 0.92074527 |
| 87 | MP0004858_abnormal_nervous_system | 0.88564024 |
| 88 | MP0009642_abnormal_blood_homeostasis | 0.88510529 |
| 89 | MP0008961_abnormal_basal_metabolism | 0.86670874 |
| 90 | MP0009278_abnormal_bone_marrow | 0.83832153 |
| 91 | MP0000920_abnormal_myelination | 0.83772456 |
| 92 | MP0005595_abnormal_vascular_smooth | 0.82841535 |
| 93 | MP0010234_abnormal_vibrissa_follicle | 0.82003061 |
| 94 | MP0003638_abnormal_response/metabolism_ | 0.80851182 |
| 95 | MP0000604_amyloidosis | 0.78599697 |
| 96 | MP0003011_delayed_dark_adaptation | 0.77984213 |
| 97 | MP0001533_abnormal_skeleton_physiology | 0.77977448 |
| 98 | MP0002405_respiratory_system_inflammati | 0.77369629 |
| 99 | MP0005381_digestive/alimentary_phenotyp | 0.76684975 |
| 100 | MP0005165_increased_susceptibility_to | 0.75185763 |
| 101 | MP0000343_altered_response_to | 0.74949552 |
| 102 | MP0003828_pulmonary_edema | 0.74239821 |
| 103 | MP0006036_abnormal_mitochondrial_physio | 0.74124205 |
| 104 | MP0005164_abnormal_response_to | 0.74005301 |
| 105 | MP0003566_abnormal_cell_adhesion | 0.73828266 |
| 106 | MP0002876_abnormal_thyroid_physiology | 0.73542471 |
| 107 | MP0005408_hypopigmentation | 0.72752828 |
| 108 | MP0002896_abnormal_bone_mineralization | 0.72745130 |
| 109 | MP0001845_abnormal_inflammatory_respons | 0.72070120 |
| 110 | MP0005535_abnormal_body_temperature | 0.71940332 |
| 111 | MP0005390_skeleton_phenotype | 0.71853612 |
| 112 | MP0005220_abnormal_exocrine_pancreas | 0.71834023 |
| 113 | MP0002090_abnormal_vision | 0.71442115 |
| 114 | MP0003690_abnormal_glial_cell | 0.70049425 |
| 115 | MP0009379_abnormal_foot_pigmentation | 0.70022160 |
| 116 | MP0002254_reproductive_system_inflammat | 0.68457856 |
| 117 | MP0009333_abnormal_splenocyte_physiolog | 0.68141430 |
| 118 | MP0009763_increased_sensitivity_to | 0.67977415 |
| 119 | MP0005464_abnormal_platelet_physiology | 0.66237687 |
| 120 | MP0006082_CNS_inflammation | 0.66118740 |
| 121 | MP0002419_abnormal_innate_immunity | 0.65829374 |
| 122 | MP0001501_abnormal_sleep_pattern | 0.64465908 |
| 123 | MP0000465_gastrointestinal_hemorrhage | 0.64307176 |
| 124 | MP0001542_abnormal_bone_strength | 0.63597271 |
| 125 | MP0010386_abnormal_urinary_bladder | 0.62640809 |
| 126 | MP0002998_abnormal_bone_remodeling | 0.62604392 |
| 127 | MP0004782_abnormal_surfactant_physiolog | 0.62100957 |
| 128 | MP0004147_increased_porphyrin_level | 0.61420578 |
| 129 | MP0000249_abnormal_blood_vessel | 0.59977988 |
| 130 | MP0002796_impaired_skin_barrier | 0.59053073 |
| 131 | MP0002971_abnormal_brown_adipose | 0.58385147 |
| 132 | MP0002295_abnormal_pulmonary_circulatio | 0.58243128 |
| 133 | MP0003183_abnormal_peptide_metabolism | 0.57559677 |
| 134 | MP0002078_abnormal_glucose_homeostasis | 0.57408249 |
| 135 | MP0005166_decreased_susceptibility_to | 0.56967202 |
| 136 | MP0001661_extended_life_span | 0.56843394 |
| 137 | MP0008004_abnormal_stomach_pH | 0.54707990 |
| 138 | MP0002089_abnormal_postnatal_growth/wei | 0.54004941 |
| 139 | MP0005376_homeostasis/metabolism_phenot | 0.53854483 |
| 140 | MP0004130_abnormal_muscle_cell | 0.53667908 |
| 141 | MP0003795_abnormal_bone_structure | 0.52549788 |
| 142 | MP0005375_adipose_tissue_phenotype | 0.52424324 |
| 143 | MP0005395_other_phenotype | 0.51415595 |
| 144 | MP0000371_diluted_coat_color | 0.49559618 |
| 145 | MP0001663_abnormal_digestive_system | 0.46891082 |
| 146 | MP0004885_abnormal_endolymph | 0.46849033 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.27436101 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.27436101 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 7.27436101 |
| 4 | Gout (HP:0001997) | 5.36988422 |
| 5 | Hypokalemic alkalosis (HP:0001949) | 5.05902968 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 5.04411042 |
| 7 | Increased circulating renin level (HP:0000848) | 4.96996196 |
| 8 | Hyperactive renin-angiotensin system (HP:0000841) | 4.85232068 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.78596742 |
| 10 | Metabolic alkalosis (HP:0200114) | 4.74048777 |
| 11 | Hyperglycinuria (HP:0003108) | 4.63767509 |
| 12 | Loss of speech (HP:0002371) | 4.47697294 |
| 13 | Abnormality of chloride homeostasis (HP:0011422) | 4.34119619 |
| 14 | Polyuria (HP:0000103) | 4.32723128 |
| 15 | Abnormal urine output (HP:0012590) | 4.26662272 |
| 16 | Hypomagnesemia (HP:0002917) | 4.26128754 |
| 17 | Disinhibition (HP:0000734) | 4.25268282 |
| 18 | Proximal tubulopathy (HP:0000114) | 4.22527993 |
| 19 | Abnormality of purine metabolism (HP:0004352) | 4.17302230 |
| 20 | Abnormality of renal excretion (HP:0011036) | 4.16135711 |
| 21 | Abnormality of macrophages (HP:0004311) | 4.15499192 |
| 22 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.95992547 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.89744051 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.89744051 |
| 25 | Hyperuricemia (HP:0002149) | 3.87760786 |
| 26 | Increased purine levels (HP:0004368) | 3.87760786 |
| 27 | Generalized aminoaciduria (HP:0002909) | 3.85406893 |
| 28 | Nuclear cataract (HP:0100018) | 3.85373678 |
| 29 | Vacuolated lymphocytes (HP:0001922) | 3.77262373 |
| 30 | Alkalosis (HP:0001948) | 3.75874934 |
| 31 | Mutism (HP:0002300) | 3.73476372 |
| 32 | Abnormality of magnesium homeostasis (HP:0004921) | 3.70953364 |
| 33 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.69807679 |
| 34 | Ketoacidosis (HP:0001993) | 3.69343579 |
| 35 | Ketosis (HP:0001946) | 3.64213316 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 3.42299055 |
| 37 | Polydipsia (HP:0001959) | 3.38262419 |
| 38 | Abnormal drinking behavior (HP:0030082) | 3.38262419 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.36839639 |
| 40 | Renal salt wasting (HP:0000127) | 3.35505052 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.33735991 |
| 42 | Tetany (HP:0001281) | 3.33692134 |
| 43 | Neurofibrillary tangles (HP:0002185) | 3.30327343 |
| 44 | Xanthomatosis (HP:0000991) | 3.28947520 |
| 45 | Abnormality of renin-angiotensin system (HP:0000847) | 3.28941645 |
| 46 | Hyperammonemia (HP:0001987) | 3.22902783 |
| 47 | Abnormality of proline metabolism (HP:0010907) | 3.22329946 |
| 48 | Hydroxyprolinuria (HP:0003080) | 3.22329946 |
| 49 | Hyperaldosteronism (HP:0000859) | 3.14504468 |
| 50 | Eczematoid dermatitis (HP:0000976) | 3.11207066 |
| 51 | Vascular calcification (HP:0004934) | 3.04137540 |
| 52 | Abnormality of urine glucose concentration (HP:0011016) | 3.02635073 |
| 53 | Glycosuria (HP:0003076) | 3.02635073 |
| 54 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.02565880 |
| 55 | Hyperglycinemia (HP:0002154) | 2.97026321 |
| 56 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.96320044 |
| 57 | Deep venous thrombosis (HP:0002625) | 2.95787242 |
| 58 | Intrahepatic cholestasis (HP:0001406) | 2.91986718 |
| 59 | Renal tubular acidosis (HP:0001947) | 2.88652907 |
| 60 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.88400727 |
| 61 | Amyloidosis (HP:0011034) | 2.84726288 |
| 62 | Hematochezia (HP:0002573) | 2.84472025 |
| 63 | Dysostosis multiplex (HP:0000943) | 2.82841183 |
| 64 | Autoimmune thrombocytopenia (HP:0001973) | 2.81000151 |
| 65 | Progressive neurologic deterioration (HP:0002344) | 2.79962197 |
| 66 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.78501389 |
| 67 | Cardiovascular calcification (HP:0011915) | 2.77915522 |
| 68 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.73508801 |
| 69 | Mucopolysacchariduria (HP:0008155) | 2.73508801 |
| 70 | Delayed CNS myelination (HP:0002188) | 2.72829340 |
| 71 | Complement deficiency (HP:0004431) | 2.66843934 |
| 72 | Hypoglycemic coma (HP:0001325) | 2.64978789 |
| 73 | Apathy (HP:0000741) | 2.62954179 |
| 74 | Recurrent bacterial skin infections (HP:0005406) | 2.62864131 |
| 75 | Recurrent abscess formation (HP:0002722) | 2.59575548 |
| 76 | Diminished motivation (HP:0000745) | 2.56453089 |
| 77 | Hypercalciuria (HP:0002150) | 2.55387013 |
| 78 | Nephrolithiasis (HP:0000787) | 2.54937410 |
| 79 | Agnosia (HP:0010524) | 2.54038962 |
| 80 | Malnutrition (HP:0004395) | 2.53464465 |
| 81 | Myocardial infarction (HP:0001658) | 2.52837622 |
| 82 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.51359259 |
| 83 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.51359259 |
| 84 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.51359259 |
| 85 | Hypokalemia (HP:0002900) | 2.51133066 |
| 86 | Prolonged neonatal jaundice (HP:0006579) | 2.47831194 |
| 87 | Peripheral demyelination (HP:0011096) | 2.44933394 |
| 88 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.42793190 |
| 89 | Hepatosplenomegaly (HP:0001433) | 2.42616017 |
| 90 | Orchitis (HP:0100796) | 2.40414779 |
| 91 | Metabolic acidosis (HP:0001942) | 2.40209591 |
| 92 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.40007506 |
| 93 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.36799557 |
| 94 | Hyperphosphaturia (HP:0003109) | 2.36198151 |
| 95 | Hypophosphatemia (HP:0002148) | 2.35615711 |
| 96 | Dementia (HP:0000726) | 2.35021294 |
| 97 | Glomerulonephritis (HP:0000099) | 2.34534621 |
| 98 | Axonal loss (HP:0003447) | 2.32673288 |
| 99 | Purpura (HP:0000979) | 2.27253537 |
| 100 | Rickets (HP:0002748) | 2.26209961 |
| 101 | Joint hemorrhage (HP:0005261) | 2.25712059 |
| 102 | Abnormal urine phosphate concentration (HP:0012599) | 2.25266670 |
| 103 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.25251812 |
| 104 | Polyphagia (HP:0002591) | 2.23123525 |
| 105 | Neuronal loss in central nervous system (HP:0002529) | 2.22584243 |
| 106 | * Dicarboxylic aciduria (HP:0003215) | 2.20263785 |
| 107 | * Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.20263785 |
| 108 | Conjunctival telangiectasia (HP:0000524) | 2.18322861 |
| 109 | Petechiae (HP:0000967) | 2.15982539 |
| 110 | Retinal atrophy (HP:0001105) | 2.13499645 |
| 111 | * Vomiting (HP:0002013) | 2.12211203 |
| 112 | Abnormality of potassium homeostasis (HP:0011042) | 2.08788265 |
| 113 | Mediastinal lymphadenopathy (HP:0100721) | 2.08732708 |
| 114 | Metaphyseal irregularity (HP:0003025) | 2.08295766 |
| 115 | Myositis (HP:0100614) | 2.07786288 |
| 116 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.07073962 |
| 117 | Inappropriate behavior (HP:0000719) | 2.06847374 |
| 118 | Abnormality of the nasal mucosa (HP:0000433) | 2.06283828 |
| 119 | Lymphangioma (HP:0100764) | 2.06263176 |
| 120 | Abnormality of complement system (HP:0005339) | 2.05998292 |
| 121 | Nephrocalcinosis (HP:0000121) | 2.05977379 |
| 122 | Cerebral inclusion bodies (HP:0100314) | 2.05756129 |
| 123 | Premature loss of primary teeth (HP:0006323) | 2.04204981 |
| 124 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.04063929 |
| 125 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.03223804 |
| 126 | Late onset (HP:0003584) | 2.03135930 |
| 127 | Enlarged kidneys (HP:0000105) | 2.02903466 |
| 128 | Nausea (HP:0002018) | 2.02224389 |
| 129 | Elevated alkaline phosphatase (HP:0003155) | 2.01143642 |
| 130 | Metaphyseal cupping (HP:0003021) | 2.00529721 |
| 131 | Hepatocellular carcinoma (HP:0001402) | 1.99181036 |
| 132 | Sensorimotor neuropathy (HP:0007141) | 1.99130308 |
| 133 | Chondrocalcinosis (HP:0000934) | 1.98594970 |
| 134 | Optic neuritis (HP:0100653) | 1.98060948 |
| 135 | Retrobulbar optic neuritis (HP:0100654) | 1.98060948 |
| 136 | Upper motor neuron abnormality (HP:0002127) | 1.96695429 |
| 137 | Increased CSF protein (HP:0002922) | 1.96087948 |
| 138 | Tetraparesis (HP:0002273) | 1.95851692 |
| 139 | Abnormal tarsal ossification (HP:0008369) | 1.94581178 |
| 140 | Bone pain (HP:0002653) | 1.94163628 |
| 141 | Widely patent fontanelles and sutures (HP:0004492) | 1.93591633 |
| 142 | Pathologic fracture (HP:0002756) | 1.93499265 |
| 143 | Fat malabsorption (HP:0002630) | 1.93232722 |
| 144 | Gingivitis (HP:0000230) | 1.92488888 |
| 145 | Chronic diarrhea (HP:0002028) | 1.92318852 |
| 146 | Nephritis (HP:0000123) | 1.92026481 |
| 147 | Dehydration (HP:0001944) | 1.91293126 |
| 148 | Esophageal varix (HP:0002040) | 1.91277232 |
| 149 | Abnormality of vitamin B metabolism (HP:0004340) | 1.91250227 |
| 150 | Steatorrhea (HP:0002570) | 1.90472710 |
| 151 | Facial shape deformation (HP:0011334) | 1.89650758 |
| 152 | Potter facies (HP:0002009) | 1.89650758 |
| 153 | Increased IgM level (HP:0003496) | 1.87707623 |
| 154 | * Lethargy (HP:0001254) | 1.87373791 |
| 155 | Hyperlipoproteinemia (HP:0010980) | 1.86986018 |
| 156 | Delayed epiphyseal ossification (HP:0002663) | 1.86005561 |
| 157 | Cardiomegaly (HP:0001640) | 1.81461536 |
| 158 | Vertebral compression fractures (HP:0002953) | 1.80589699 |
| 159 | Increased serum ferritin (HP:0003281) | 1.79693918 |
| 160 | Asymmetric septal hypertrophy (HP:0001670) | 1.79623986 |
| 161 | Mucosal telangiectasiae (HP:0100579) | 1.79549712 |
| 162 | Confusion (HP:0001289) | 1.78061929 |
| 163 | Spontaneous hematomas (HP:0007420) | 1.76116528 |
| 164 | Subcapsular cataract (HP:0000523) | 1.76062246 |
| 165 | Zonular cataract (HP:0010920) | 1.75924902 |
| 166 | Abnormality of vitamin metabolism (HP:0100508) | 1.75213812 |
| 167 | Abnormality of the periventricular white matter (HP:0002518) | 1.73527253 |
| 168 | Personality changes (HP:0000751) | 1.73492719 |
| 169 | Wide cranial sutures (HP:0010537) | 1.71687787 |
| 170 | Bone cyst (HP:0012062) | 1.69518846 |
| 171 | Interstitial pulmonary disease (HP:0006530) | 1.69098461 |
| 172 | Polygenic inheritance (HP:0010982) | 1.68723075 |
| 173 | Posterior subcapsular cataract (HP:0007787) | 1.67412890 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 5.74228998 |
| 2 | WNK3 | 4.62613183 |
| 3 | ACVR1B | 4.60585870 |
| 4 | OXSR1 | 4.14215542 |
| 5 | BCKDK | 4.11047753 |
| 6 | ERN1 | 3.55143842 |
| 7 | NME2 | 3.16645974 |
| 8 | KDR | 3.01324406 |
| 9 | TGFBR2 | 2.86862916 |
| 10 | STK16 | 2.83225780 |
| 11 | TIE1 | 2.74586436 |
| 12 | DDR2 | 2.68386296 |
| 13 | STK39 | 2.39365352 |
| 14 | MST1R | 2.35646842 |
| 15 | GRK7 | 2.23327815 |
| 16 | TRIB3 | 2.20856352 |
| 17 | EPHB1 | 2.14883801 |
| 18 | FGFR4 | 2.06920115 |
| 19 | TESK2 | 2.04082174 |
| 20 | FGR | 1.97809550 |
| 21 | TNIK | 1.87747895 |
| 22 | TAOK2 | 1.77074014 |
| 23 | TESK1 | 1.75672599 |
| 24 | SIK1 | 1.67983142 |
| 25 | PIM2 | 1.57316031 |
| 26 | PTK6 | 1.56702020 |
| 27 | STK38L | 1.52860233 |
| 28 | RIPK1 | 1.50298652 |
| 29 | PKN2 | 1.46873304 |
| 30 | LRRK2 | 1.32828974 |
| 31 | PDK2 | 1.28537274 |
| 32 | CDC42BPA | 1.26534495 |
| 33 | ADRBK2 | 1.26071427 |
| 34 | MOS | 1.24610246 |
| 35 | MET | 1.20301497 |
| 36 | MAP3K3 | 1.19277590 |
| 37 | PRPF4B | 1.17552590 |
| 38 | INSRR | 1.17205236 |
| 39 | TYK2 | 1.16867511 |
| 40 | MAP2K3 | 1.14270607 |
| 41 | PDK3 | 1.13241696 |
| 42 | PDK4 | 1.13241696 |
| 43 | IRAK3 | 1.11340502 |
| 44 | IKBKE | 1.09485427 |
| 45 | PAK4 | 1.05874224 |
| 46 | TAOK1 | 1.05484752 |
| 47 | MAPK15 | 1.05484258 |
| 48 | CAMK1D | 1.01141893 |
| 49 | BLK | 1.00404036 |
| 50 | TBK1 | 0.98411476 |
| 51 | MYLK | 0.95891059 |
| 52 | RIPK4 | 0.94336956 |
| 53 | TAOK3 | 0.93712332 |
| 54 | PTK2 | 0.93461344 |
| 55 | MAP3K1 | 0.93236825 |
| 56 | GRK6 | 0.92089913 |
| 57 | IKBKB | 0.90415671 |
| 58 | SGK494 | 0.89426640 |
| 59 | SGK223 | 0.89426640 |
| 60 | MAP3K14 | 0.89332387 |
| 61 | FLT3 | 0.86707133 |
| 62 | GSK3A | 0.86139259 |
| 63 | WNK1 | 0.84882714 |
| 64 | JAK1 | 0.82924660 |
| 65 | CSK | 0.81420837 |
| 66 | DMPK | 0.80841040 |
| 67 | STK10 | 0.80486799 |
| 68 | FRK | 0.78013715 |
| 69 | MAP4K1 | 0.77645279 |
| 70 | JAK2 | 0.76892286 |
| 71 | SGK3 | 0.74099583 |
| 72 | ZAP70 | 0.72944064 |
| 73 | MAP3K12 | 0.72718664 |
| 74 | LYN | 0.71942700 |
| 75 | NEK9 | 0.69930032 |
| 76 | TGFBR1 | 0.68937041 |
| 77 | FES | 0.67185481 |
| 78 | MST4 | 0.66428331 |
| 79 | DYRK1B | 0.66409871 |
| 80 | MAP2K2 | 0.65965641 |
| 81 | CAMK1G | 0.65950401 |
| 82 | PRKAA2 | 0.65256852 |
| 83 | MAPK11 | 0.64734896 |
| 84 | NEK1 | 0.64313498 |
| 85 | ARAF | 0.63655598 |
| 86 | BTK | 0.63510059 |
| 87 | MAP3K11 | 0.63436428 |
| 88 | PIK3CG | 0.62976226 |
| 89 | DAPK3 | 0.60843121 |
| 90 | EPHA3 | 0.60470907 |
| 91 | STK38 | 0.60178884 |
| 92 | FER | 0.60050273 |
| 93 | ABL2 | 0.59280310 |
| 94 | MAP3K7 | 0.58692548 |
| 95 | LIMK1 | 0.57336164 |
| 96 | BMX | 0.57152843 |
| 97 | KIT | 0.55832872 |
| 98 | STK24 | 0.55330948 |
| 99 | NLK | 0.55187281 |
| 100 | LATS1 | 0.53323324 |
| 101 | PDPK1 | 0.52751519 |
| 102 | MAP3K5 | 0.52615815 |
| 103 | CSF1R | 0.49870639 |
| 104 | PIM1 | 0.49243897 |
| 105 | MAPK7 | 0.49169192 |
| 106 | SIK3 | 0.49029191 |
| 107 | EPHB2 | 0.46807407 |
| 108 | MAP2K6 | 0.45608083 |
| 109 | IRAK2 | 0.45576649 |
| 110 | LMTK2 | 0.44293322 |
| 111 | MAPK12 | 0.43246489 |
| 112 | EPHA2 | 0.42968320 |
| 113 | ITK | 0.42375680 |
| 114 | TTN | 0.41317078 |
| 115 | JAK3 | 0.41279328 |
| 116 | MATK | 0.41163456 |
| 117 | PTK2B | 0.40663470 |
| 118 | IGF1R | 0.40538352 |
| 119 | MAP3K8 | 0.38549355 |
| 120 | PRKAA1 | 0.38511787 |
| 121 | PINK1 | 0.38304821 |
| 122 | CHUK | 0.38240188 |
| 123 | SGK2 | 0.36398322 |
| 124 | CDK19 | 0.36285791 |
| 125 | MAPKAPK3 | 0.35959942 |
| 126 | PDGFRA | 0.35754663 |
| 127 | TEC | 0.35093949 |
| 128 | PRKCD | 0.34183952 |
| 129 | GRK1 | 0.34110647 |
| 130 | PRKG2 | 0.33906313 |
| 131 | IRAK4 | 0.33238172 |
| 132 | SRC | 0.31424856 |
| 133 | CDK6 | 0.31081213 |
| 134 | DAPK2 | 0.31015023 |
| 135 | IRAK1 | 0.30858383 |
| 136 | INSR | 0.29769920 |
| 137 | PDK1 | 0.28110573 |
| 138 | EGFR | 0.27697986 |
| 139 | PBK | 0.26730577 |
| 140 | LCK | 0.26566871 |
| 141 | MAPK4 | 0.26484745 |
| 142 | MAP3K10 | 0.25962621 |
| 143 | MAP3K2 | 0.25683513 |
| 144 | ERBB4 | 0.24917678 |
| 145 | PRKACG | 0.24395295 |
| 146 | FGFR3 | 0.24149198 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.42663899 |
| 2 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.89335926 |
| 3 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.87006496 |
| 4 | Asthma_Homo sapiens_hsa05310 | 2.73401088 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.72110764 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.62767816 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.59595835 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.57277665 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.43055272 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.34984172 |
| 11 | Peroxisome_Homo sapiens_hsa04146 | 2.31154195 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.29554084 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.24734273 |
| 14 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.24698546 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.19500327 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.18836406 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.16646566 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.11446045 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.07629561 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.07157800 |
| 21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.02795161 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.98206645 |
| 23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.94607682 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.94126362 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.92612052 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.82399003 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.81214638 |
| 28 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.81151732 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.79967942 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.76125953 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.72254933 |
| 32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.68968326 |
| 33 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.66903370 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.64955552 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.63518135 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.59398596 |
| 37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.57945024 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.53615569 |
| 39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.44395130 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.42682427 |
| 41 | Carbon metabolism_Homo sapiens_hsa01200 | 1.41324517 |
| 42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.36180136 |
| 43 | * Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.34950377 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.34153806 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.32669860 |
| 46 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.31779086 |
| 47 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.28283856 |
| 48 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.27902896 |
| 49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.25346079 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 1.24474010 |
| 51 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.23571652 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.23565730 |
| 53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.21340811 |
| 54 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.20830363 |
| 55 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19255073 |
| 56 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.15195163 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12983870 |
| 58 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.12613981 |
| 59 | Lysosome_Homo sapiens_hsa04142 | 1.12319635 |
| 60 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.07344916 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 1.05550512 |
| 62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02975671 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00393228 |
| 64 | Salmonella infection_Homo sapiens_hsa05132 | 0.98780266 |
| 65 | Retinol metabolism_Homo sapiens_hsa00830 | 0.97946569 |
| 66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97334227 |
| 67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.95973964 |
| 68 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.94438396 |
| 69 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.94261097 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.91565507 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.90364561 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.89697556 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.88812291 |
| 74 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.87800335 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.84899071 |
| 76 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.84748347 |
| 77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.83758294 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.83248362 |
| 79 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.82861355 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.81023573 |
| 81 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78084418 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.76424714 |
| 83 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.74657677 |
| 84 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72342401 |
| 85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71985524 |
| 86 | Influenza A_Homo sapiens_hsa05164 | 0.70126048 |
| 87 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68956831 |
| 88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66583764 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.64907495 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64891186 |
| 91 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.62749268 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.62604536 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.62351019 |
| 94 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.61132553 |
| 95 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.60997655 |
| 96 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.60657860 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58352038 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56078468 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55466045 |
| 100 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.54249790 |
| 101 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.54188332 |
| 102 | Sulfur relay system_Homo sapiens_hsa04122 | 0.50799225 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49700977 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47960418 |
| 105 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.45323689 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44879355 |
| 107 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43016982 |
| 108 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.42921671 |
| 109 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38277124 |
| 110 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.38248485 |
| 111 | Proteasome_Homo sapiens_hsa03050 | 0.37256209 |
| 112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.36615660 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.36536977 |
| 114 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.36271861 |
| 115 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.32142478 |
| 116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.32047473 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31448922 |
| 118 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.27515614 |
| 119 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.25099796 |
| 120 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.21861836 |
| 121 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.21078039 |
| 122 | Malaria_Homo sapiens_hsa05144 | 0.15011069 |
| 123 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.14449082 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.12707788 |
| 125 | Pertussis_Homo sapiens_hsa05133 | 0.12707162 |
| 126 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.09733365 |
| 127 | Phagosome_Homo sapiens_hsa04145 | 0.09280821 |
| 128 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.07883464 |
| 129 | Amoebiasis_Homo sapiens_hsa05146 | 0.06369296 |
| 130 | Hepatitis C_Homo sapiens_hsa05160 | 0.05821906 |
| 131 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.05190372 |
| 132 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.04590134 |
| 133 | Leishmaniasis_Homo sapiens_hsa05140 | 0.03687297 |
| 134 | Legionellosis_Homo sapiens_hsa05134 | 0.03687136 |
| 135 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02767303 |
| 136 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.02466678 |

